In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
With more stability in racing dates in the Mid-Atlantic region, the chairman of the THA plans to hold a fact-finding meeting to see if there is interest in bringing back the MATCH series.
- By Tom LaMarra
A horsemen's group official involved in development of the proposed model rule for multiple violation penalties said July 15 the regulations are a "living document" that probably will be adjusted based on industry needs.
Racing Commissioners International gave final approval April 2 to the "RCI Controlled Therapeutic Medication Schedule," setting the stage for uniform implementation of racing medication rules in the U.S.
The regulators of eight states in the Northeast region have committed to a uniform medication and drug testing program in a move supporters believe is a step toward uniform regulation of medication and drug testing.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
Industry stakeholders, mostly from the Mid-Atlantic and Northeast, met Feb. 6 in Delaware to examine equine medication policy in an attempt to bring about uniformity from state to state.
With regulators and industry groups leading the charge, many horse racing stakeholders believe sweeping medication reform could become a reality in early 2013.
The Pennsylvania Thoroughbred Horsemen's Association, which represents horsemen at Parx Racing, is back under the umbrella of the Thoroughbred Horsemen's Association, the parties said Dec. 14.
- By Tom LaMarra
Horsemen's groups largely support proposed changes in race-day medication rules but are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
A controversial model rule that increases losing mount fees for jockeys generated lively debate Dec. 8 when both sides presented their case.
While signal distribution at racetracks continues to be a hot topic in the horse racing industry, that doesn't appear to be the case at Hawthorne Race Course, which opens its meet Sept. 26.
The Florida Horsemen's Benevolent and Protective Association issued a statement July 8 thanking Calder horsemen who "took the full brunt" of purse cuts during a 2 1/2-month dispute with track owner Churchill Downs Inc.
Eight horsemen?s groups from around the United States have joined together to form a coalition designed to improve racing economics, specifically in the area of generating more purse revenue from interstate simulcasts.
Major horsemen's groups have banded together to ask racetracks and account wagering providers to make the Triple Crown races available to all wagering services in light of a conflict that is spreading ill will as horse racing's most prominent and lucrative day approaches.
Though questions persist about TrackNet Media Group, the entity formed by Churchill Downs Inc. and Magna Entertainment Corp. to buy and sell simulcast signals, it has generated an initial positive response from one of the country's major horsemen's groups.
Representatives of horsemen's groups criticized for not supporting the Permanently Disabled Jockeys Fund questioned jockeys' support for the fund and said pursuit of legislation that would amend the Interstate Horseracing Act has damaged relations between horsemen and jockeys.
The Board of Directors of the Racing Medication and Testing Consortium approved a plan developed by Dr. Rick Sams of The Ohio State University to establish guidelines for withdrawal times for therapeutic medications utilized by racetrack veterinarians.
The Racing Medication and Testing Consortium expects to have enough money to carry it through 2006, but an official with the group indicated it's imperative more racetrack and horsemen's associations commit funds to the organization.
The Florida Horsemen's Benevolent and Protective Association, whose board of directors has considered leaving the National HBPA since earlier this year, made it official Nov. 11.
- By Ray Paulick
By Ray Paulick -- As a move toward uniform drug rules progresses, it's obvious that no policy will please everyone.
Mid-Atlantic regulators and the Thoroughbred Horsemen's Association are scheduled to meet June 12 in New Jersey to discuss medication and drug-testing issues on a regional and national scope.
The Racing Medication and Testing Consortium is scheduled to meet Feb. 4 in Atlanta, Ga., to hammer out details of its structure and further develop its policy statement.
Organization bylaws and changes in the industry landscape could lead the National Thoroughbred Racing Association to tweak its structure when the board of directors meets in early February for a meeting and long-range planning retreat. Meanwhile, the Thoroughbred Owners and Breeders Association has named John Amerman as its new NTRA representative.
The seven-month racing series known as Mid-Atlantic Thoroughbred Championships (MATCH) will not take place this year because of turmoil in two key racing states.
Setting a national policy for racehorse medication is a vital step for the sport's long-term health, a top industry executive told the 2002 Harness Racing Congress in Las Vegas, Nev., Feb. 20.
California is on board with a nationwide push for a consensus on racehorse medication, the president of the Thoroughbred Owners of California reported to his board the week of Dec. 10. But the TOC does have its own opinions on some of the specifics.
The Kentucky Horsemen's Benevolent and Protective Association has taken issue with the conduct of the state's Equine Drug Council and has asked the Kentucky Racing Commission to make sure the council complies with regulations.
The Thoroughbred Horsemen's Association hopes to release a sweeping national medication and drug-testing proposal either before or during the University of Arizona Symposium on Racing, which begins Dec. 4. It would become the second major horsemen's group to issue a medication proposal this fall.
Most Popular Stories
- First Reported Foal for Rattlesnake Bridge
- Through the Lens: Wise Dan Photo Gets Award
- Australian Vets Support New Racing Rule on Cobalt
- Final Call for Taylors of Seattle Slew Fame
- 'Chrome' Tops U.S. Nominees for World Cup
- Subjective vs. Objective Lameness Identification Methods
- Jockey Chapa Faces Felony Race-Fixing Charges
- New Leadership Coming for Illinois Board
- Flashy Performances at OBS Day of Champions
- Steve Haskin's Derby Dozen for Jan. 27, 2015